Lonza makes a solid start to 2019
08:17 AM | April 18, 2019 | Michael Ravenscroft
The company's pharma biotech and nutrition segment performed strongly, but the specialty ingredients business met unforeseen challenges.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.